| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.6 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |